Does aprotinin really reduces blood loss during orthotopic liver transplantation?
Ickx, B.; Pradier, O.; De Groote, F.; Hendrice, C.; Gelin, M.; Van De Stadt, T.J.; Capel, P.
Hepatology 18(3): 740
1993
ISSN/ISBN: 0270-9139 Accession: 030992630
Full Text Article emailed within 1 workday: $29.90
Related References
Kratzer, M.A.A.; Azad, S.C.; Groh, J.; Welte, M.; Haller, M.; Pratschke, E. 1997: Die Wirkung von Aprotinin : Blutverlust und Gerinnungsparameter bei orthotoper Lebertransplantation : Eine klinisch-experimentelle, prospektive und randomisierte Doppelblindstudie - Effect of aprotinin on blood loss and coagulation parameters in orthotopic liver transplantation der Anaesthesist (Berlin. Print) 46(4): 294-302Groh, J.; Welte, M.; Azad, S.C.; Anthuber, M.; Haller, M.; Kratzer, M.A. 1993: Does aprotinin really reduce blood loss in orthotopic liver transplantation? Seminars in Thrombosis and Hemostasis 19(3): 306-308
Légaré, G.; Roy, A.; Dagenais, M.; Lapointe, R.; Marleau, D.; Thuot, C. 1996: Reduction of blood loss in orthotopic liver transplantation with the use of aprotinin Annales de Chirurgie 50(8): 601-605
Kratzer, M.A.A.; Azad, S.C.; Groh, J.; Welte, M.; Haller, M.; Pratschke, E. 1997: Effect of aprotinin on blood loss and coagulation parameters in orthotopic liver transplantation Anaesthesist 46(4): 294-302
Mallett, S.V.; Cox, D.; Burroughs, A.K.; Rolles, K. 1990: Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation Lancet 336(8719): 886-887
Kufner, R.P.; Ereth, M.H.; Krom, R.A.F.; Findlay, J.Y.; Rettke, S.R. 1998: Aprotinin significantly reduces red blood cell transfusion requirements in patients undergoing orthotopic liver transplantation Anesthesiology 89(3A): A267
Arnoux, D.; Boutiere, B.; Lassale, B.; Le Treut, Y.P.; Sampol, J. 1996: Comparative effect of two doses of aprotinin on fibrinolysis and blood loss in orthotopic liver transplantation Fibrinolysis 10(Suppl 3): 49
Findlay, J.Y.; Rettke, S.R.; Ereth, M.H.; Plevak, D.J.; Krom, R.A.; Kufner, R.P. 2001: Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 7(9): 802-807
Kratzer, M.A.; Azad, S.C.; Groh, J.; Welte, M.; Haller, M.; Pratschke, E. 1997: The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: a clinical-experimental, prospective and randomized double-blind study Der Anaesthesist 46(4): 294-302
Khaled, Y.A.S.S.E.N.; Bellamy, M.C.; Sadek, S.A.; Webster, N.R. 1993: Tranexamic acid reduces blood loss during orthotopic liver transplantation Clinical Transplantation 7(5): 453-458
Boylan, J.F.; Klinck, J.R.; Sandler, A.N.; Arellano, R.; Greig, P.D.; Nierenberg, H.; Roger, S.L.; Glynn, M.F. 1996: Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation Anesthesiology 85(5): 1043-8; discussion 30A-31A
Boylan, J.F.; Klinck, J.R.; Sandler, A.N.; Arellano, R.; Greig, P.D.; Nierenberg, H.; Roger, S.L.; Glynn, M.F.X.; Phil, D. 1996: Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation Anesthesiology (Philadelphia) 85(5): 1043-1048
Bechstein, W.O.; Riess, H.; Neuhaus, P.; Himmelreich, G.; Steffen, R.; Slama, K.J.; Rossaint, R.; Blumhardt, G. 1991: The effect of aprotinin on blood product requirements during orthotopic liver transplantation Clinical Transplantation 5(6): 422-426
Lassale, B.; Rathelot, P.; Angelini, B.; Bongrand, M.C.; Timon-David, P. 1996: Aprotinin in orthotopic liver transplantation (OLT): Clinical and economical interest in blood requirements Journal de Pharmacie Clinique 15(3): 187-191
Llamas, P.; Cabrera, R.; Gómez-Arnau, J.; Fernández, M.N. 1998: Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin Haematologica 83(4): 338-346